Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
Asset
(67)
News
(28)
SEC filing
(21)
Event
(19)
Filter by content year
(-)
2024
(135)
Filter by form group
Filter by category
Filter by category
Search
News
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
Asset
Grundsatzerklärung Menschenrechte
Grundsatzerklärung Menschenrechte
346.8 KB
Asset
BioNTech - Board Diversity Matrix 2022
BioNTech - Board Diversity Matrix 2022
19.3 KB
Asset
Board Diversity Matrix 2023
Board Diversity Matrix 2023
65 KB
SEC Filings
Form 6-K
Asset
J.P. Morgan Healthcare Conference Presentation
J.P. Morgan Healthcare Conference Presentation
2.1 MB
Asset
J.P. Morgan Healthcare Conference Presentation
J.P. Morgan Healthcare Conference Presentation
2.1 MB
Event
42nd Annual J.P. Morgan Healthcare Conference
Event
42nd Annual J.P. Morgan Healthcare Conference
Asset
Modern Slavery Act Statement 2022
Modern Slavery Act Statement 2022
3.1 MB
Pagination
Previous page
‹‹
Page 2
Next page
››